GEA Group Hits All-Time High – Food, Pharma, and Dairy Business Drive Growth
Reading Time: 3 minutes
Dairy processing, food, beverages, and pharmaceuticals drive the story: New growth opportunities arise, among other things, through continuous tablet production. The order intake remains strong: For Q3, GEA again indicates around 10% organic growth and over 6 billion euros in orders by 2026. Growth and profitability are advancing simultaneously: After a strong Q2, GEA raised its annual forecast and benefits from increasing margins. The stock of the GEA Group (G1A) continues its long-term upward trend. Since the beginning of the year, it...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
